tradingkey.logo
搜索

Inovio Pharmaceuticals Inc

INO
添加自选
0.677USD
+0.021+3.20%
收盘 07-31 16:00美东报价延迟15分钟
47.24M总市值
亏损市盈率 TTM

INO 财务数据

通过专为投资者打造的一站式数据看板,全面查看 Inovio Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

Inovio Pharmaceuticals Inc财报日历

最新发布
5月 13, 2026
每股收益 / 预测值
-0.28/-0.35
营业收入 / 预测值
0.00/250.00K
报告期
FY2025 财报
营业收入(YoY)
65.34K
-69.99%
每股收益(YoY)
-1.81
54.12%
分析师评级
BUY
2026/08/01
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
44.15%-0.28
109.39%0.06
2.48%-0.87
48.90%-0.61
61.01%-0.51
41.24%-0.65
41.00%-0.89
26.52%-1.19
30.69%-1.31
57.83%-1.10
---1.52
---1.61
---1.89
---2.61
----
----
----
----
----
----
营业收入
-100.00%0.00
-100.00%0.00
--0.00
-100.00%0.00
--65.34K
13.97%116.99K
-100.00%0.00
-55.41%100.76K
-100.00%0.00
-17.66%102.65K
-95.76%388.45K
-71.19%225.97K
-42.26%114.94K
-85.14%124.67K
3038.22%9.15M
187.51%784.39K
-46.36%199.07K
-84.96%839.12K
23.51%291.70K
2.11%272.82K
净利润
0.06%-19.68M
119.42%3.76M
-80.79%-45.50M
27.04%-23.52M
35.36%-19.69M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
54.09%-25.00M
10.20%-33.93M
67.25%-35.53M
48.59%-40.65M
49.07%-54.46M
37.20%-37.78M
-32.09%-108.50M
-45.35%-79.07M
-339.42%-106.95M
-413.85%-60.17M
36.18%-82.14M
利润率
----
----
----
----
---30140.48%
31.99%-16566.39%
----
-103.45%-31993.31%
----
44.24%-24357.91%
---8734.77%
---15725.26%
---35364.76%
---43687.24%
----
----
----
----
----
----
毛利率
----
----
----
----
--100.00%
0.00%100.00%
----
0.00%100.00%
----
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
资产负债率
----
----
----
----
----
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
93.37%9.81%
--8.54%
--7.17%
--6.15%
--5.07%
----
----
----
----
----
----
营业收入
-100.00%0.00
-100.00%0.00
--0.00
-100.00%0.00
--65.34K
13.97%116.99K
-100.00%0.00
-55.41%100.76K
-100.00%0.00
-17.66%102.65K
-95.76%388.45K
-71.19%225.97K
-42.26%114.94K
-85.14%124.67K
3038.22%9.15M
187.51%784.39K
-46.36%199.07K
-84.96%839.12K
23.51%291.70K
2.11%272.82K
营业利润
12.38%-21.95M
14.20%-17.48M
22.44%-21.21M
30.46%-23.08M
19.89%-25.05M
25.64%-20.37M
-9.22%-27.35M
5.26%-33.20M
28.85%-31.27M
51.04%-27.39M
29.97%-25.04M
66.35%-35.04M
38.73%-43.95M
46.97%-55.95M
40.36%-35.76M
-25.16%-104.14M
-36.49%-71.73M
-259.61%-105.51M
-65.03%-59.95M
-150.75%-83.20M
净利润
0.06%-19.68M
119.42%3.76M
-80.79%-45.50M
27.04%-23.52M
35.36%-19.69M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
54.09%-25.00M
10.20%-33.93M
67.25%-35.53M
48.59%-40.65M
49.07%-54.46M
37.20%-37.78M
-32.09%-108.50M
-45.35%-79.07M
-339.42%-106.95M
-413.85%-60.17M
36.18%-82.14M
流动资产
-45.14%39.44M
-37.52%61.12M
-39.55%55.18M
-55.17%52.70M
-35.63%71.89M
-36.11%97.83M
-47.77%91.28M
-42.17%117.56M
-52.25%111.68M
-51.43%153.11M
-50.10%174.77M
-51.16%203.28M
-41.51%233.90M
-29.70%315.24M
-28.15%350.21M
-23.27%416.19M
-32.04%399.91M
-4.82%448.44M
29.26%487.40M
41.97%542.42M
流动负债总额
38.78%37.92M
23.62%43.67M
197.13%69.82M
20.11%31.71M
16.78%27.33M
-17.02%35.33M
-46.24%23.50M
-49.17%26.40M
-57.57%23.40M
-56.05%42.57M
-53.95%43.71M
-60.38%51.93M
-7.09%55.15M
47.35%96.87M
84.75%94.91M
153.27%131.06M
42.90%59.36M
57.63%65.74M
24.51%51.38M
36.25%51.75M
总资产
-42.96%49.78M
-34.35%74.31M
-35.19%69.39M
-49.00%68.24M
-32.41%87.27M
-33.78%113.20M
-44.56%107.06M
-42.59%133.80M
-51.57%129.11M
-50.95%170.95M
-50.74%193.10M
-49.27%233.04M
-40.16%266.58M
-29.72%348.53M
-26.84%391.97M
-22.38%459.40M
-31.97%445.51M
-8.12%495.94M
22.37%535.76M
33.54%591.84M
总负债
21.34%43.71M
12.35%50.21M
130.03%77.11M
7.16%39.71M
3.89%36.02M
-16.62%44.69M
-38.99%33.52M
-41.79%37.06M
-48.53%34.67M
-57.52%53.60M
-56.15%54.94M
-60.63%63.67M
-25.50%67.37M
31.06%126.17M
52.42%125.27M
94.18%161.73M
23.44%90.43M
22.43%96.27M
-27.79%82.19M
-67.57%83.29M
总权益
-88.16%6.07M
-64.82%24.10M
-110.50%-7.72M
-70.51%28.53M
-45.73%51.25M
-41.62%68.50M
-46.77%73.54M
-42.88%96.74M
-52.59%94.44M
-47.23%117.35M
-48.20%138.16M
-43.10%169.37M
-43.90%199.21M
-44.36%222.36M
-41.20%266.70M
-41.47%297.67M
-38.95%355.09M
-13.33%399.67M
39.99%453.57M
172.89%508.55M
经营净额
19.66%-21.59M
1.49%-19.37M
21.39%-21.57M
26.23%-20.81M
6.56%-26.87M
25.16%-19.66M
5.73%-27.44M
12.70%-28.21M
21.56%-28.76M
27.69%-26.28M
56.85%-29.11M
36.05%-32.31M
40.75%-36.66M
4.09%-36.34M
-45.12%-67.47M
35.60%-50.53M
-17.05%-61.88M
26.02%-37.89M
37.31%-46.49M
-188.97%-78.46M
投资净额
5193.15%2.64M
-100.17%-58.19K
-37.01%8.87M
-47.00%5.28M
-100.11%-51.75K
73.71%34.64M
356.25%14.08M
-81.51%9.97M
138.86%45.38M
-63.07%19.94M
-112.33%-5.49M
623.16%53.91M
-10.93%19.00M
931.55%54.00M
-20.38%44.56M
-120.48%-10.30M
107.75%21.33M
-74.75%-6.49M
43.06%55.96M
218.69%50.31M
融资净额
-7.21%953.79K
-6.90%27.13M
3672.40%24.92M
-100.11%-34.78K
109.05%1.03M
1485.47%29.15M
-5.44%660.65K
1045.85%33.03M
-2575.77%-11.36M
-72.43%1.84M
-81.67%698.63K
-93.29%2.88M
-101.49%-424.70K
-85.99%6.67M
964.73%3.81M
1147.71%42.94M
-82.34%28.42M
-62.51%47.59M
74.00%-440.78K
-97.28%3.44M

常见问题

Inovio Pharmaceuticals Inc的总收入是多少?

根据Inovio Pharmaceuticals Inc的FY2025财报,总收入达到了65.34K(同比变化217.76K)。

Inovio Pharmaceuticals Inc的流动资产是多少?

根据Inovio Pharmaceuticals Inc的FY2025财报,流动资产为61.12M(同比变化-37.52)。

Inovio Pharmaceuticals Inc的总资产是多少?

根据Inovio Pharmaceuticals Inc的FY2025财报,Inovio Pharmaceuticals Inc的总资产为74.31M(同比变化-34.35)。

Inovio Pharmaceuticals Inc的总负债是多少?

根据Inovio Pharmaceuticals Inc的FY2025财报,Inovio Pharmaceuticals Inc的总负债为50.21M(同比变化12.35)。

Inovio Pharmaceuticals Inc的总权益是多少?

根据Inovio Pharmaceuticals Inc的FY2025财报,Inovio Pharmaceuticals Inc的总权益为24.10M(同比变化-64.82)。

Inovio Pharmaceuticals Inc的净营业收入是多少?

根据Inovio Pharmaceuticals Inc的FY2025财报,Inovio Pharmaceuticals Inc的净营业收入为-86.82M(同比变化22.76)。

Inovio Pharmaceuticals Inc的净投资是多少?

根据Inovio Pharmaceuticals Inc的FY2025财报,Inovio Pharmaceuticals Inc的净投资为14.04M(同比变化-86.51)。

Inovio Pharmaceuticals Inc的净融资是多少?

根据Inovio Pharmaceuticals Inc的FY2025财报,Inovio Pharmaceuticals Inc的净融资为53.05M(同比变化3.06)。

Inovio Pharmaceuticals Inc的每股收益(EPS)是多少?

根据Inovio Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-1.81(同比变化54.12)。

Inovio Pharmaceuticals Inc的净利润是多少?

根据Inovio Pharmaceuticals Inc的FY2025财报,净利润为-84.95M(同比变化20.80)。

Inovio Pharmaceuticals Inc的净利润率是多少?

根据Inovio Pharmaceuticals Inc的FY2025财报,净利润率为-130000.00(同比变化-163.94)。

Inovio Pharmaceuticals Inc的股东权益回报率(ROE)是多少?

根据Inovio Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-183.47(同比变化-58.96)。

Inovio Pharmaceuticals Inc的资产回报率(ROA)是多少?

根据Inovio Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-90.61(同比变化-20.02)。

Inovio Pharmaceuticals Inc的营业利润是多少?

根据Inovio Pharmaceuticals Inc的FY2025财报,营业利润为-86.82M(同比变化22.76)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有